Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Non-Current Assets (2020 - 2025)

Intelligent Bio Solutions has reported Non-Current Assets over the past 5 years, most recently at $5.2 million for Q2 2024.

  • For Q2 2024, Non-Current Assets fell 19.21% year-over-year to $5.2 million; the TTM value through Jun 2024 reached $5.2 million, down 19.21%, while the annual FY2024 figure was $5.2 million, 19.21% down from the prior year.
  • Non-Current Assets for Q2 2024 was $5.2 million at Intelligent Bio Solutions, down from $5.5 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $11.7 million in Q4 2022 and troughed at $135692.0 in Q2 2020.
  • A 5-year average of $4.1 million and a median of $3.7 million in 2021 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: soared 2591.63% in 2021 and later crashed 59.36% in 2022.
  • Year by year, Non-Current Assets stood at $135692.0 in 2020, then surged by 748.24% to $1.2 million in 2021, then skyrocketed by 913.9% to $11.7 million in 2022, then plummeted by 49.59% to $5.9 million in 2023, then decreased by 10.84% to $5.2 million in 2024.
  • Business Quant data shows Non-Current Assets for INBS at $5.2 million in Q2 2024, $5.5 million in Q1 2024, and $5.9 million in Q4 2023.